Effect of Coenzyme Q10 and green tea on plasma and liver lipids, platelet aggregation, TBARS production and erythrocyte Na leak in simvastatin treated hypercholesterolmic rats |
Kim, Yang-Hee
(Department of Foods & Nutrition, Cheju National University)
Moon, Young-In (Jeju Agricultural Development and Technology Extention Center) Kang, Young-Hee (Division of life Sciences and Institute of Environment and Life Science, Hallym University) Kang, Jung-Sook (Department of Foods & Nutrition, Cheju National University) |
1 | Aggarwal D, West KL, Zern TL, Shrestha S & Fernandez ML (2005). JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs. BMC Cardiovasc Disord. 27; 5:30:1-8 |
2 | Davis HR Jr, Pula KK, Burrier RE & Watkins RW (2001). The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors in dogs. Metabolism 50:1234-1241 DOI ScienceOn |
3 | Fernandez ML (2001). Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr 131:10-20 |
4 | Kang JS, Cregor MD & Smith JB (1990). Effect of calcium on blood pressure, platelet aggregation and erythrocyte sodium transport in Dahl salt-sensitive rats. J Hypertens. 8:245-250 |
5 | King DE, Mainous AG, Player A & Geesey ME (2007). Use of statins and blood pressure. Am J Hypertens 20:937-941 DOI ScienceOn |
6 | Naseem KM & Bruckdorfer KR (1999). The influence of organic peroxides on platelet aggregation and sensitivity to nitric oxide. Platelets 10:146-152 DOI |
7 | Nawarskas JJ (2005) HMG-CoA reductase inhibitors and coenzyme Q10. Cardiol Rev 13:76-79 DOI ScienceOn |
8 | Pentaceska SS, DeRosa S, Olm V, Diaz N, Pappolla M & Refolo LM (2002). Statin therapy for alzheimer' disease; will it work? J Mol Neurisci 10:155-161 |
9 | Raederstorff DG, Schlachter MF, Elste V & Weber P (2003) Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14:326-332 DOI ScienceOn |
10 | Sawada M, Matsuo M & Seki J (2002). Inhibition of cholesterol synthesis causes both hypercholesterolemia and hypocholesterolemia in hamsters. Biol Pharm Bull 25:1577-1582 DOI ScienceOn |
11 | Tavintharan S, Ong CN, Sivakumar M, Lim SC & Sum CF (2007). Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity? Toxicol Appl Pharmacol 223:173-179 DOI ScienceOn |
12 | Zacco A Togo J, Spence K, Furlong S & Piser T (2003). HMG CoA reductase inhibitor protect cortical neurons from excitotoxicity. J Neurosci 23:11104-11111 DOI |
13 | Dietscht JM, Turley SD & Spady DK (1993). Role of the liver in the maintenance of cholesterol and low density lipoprotein in homeostasis in different animal species including human. J Lipid Res 34:1637-1659 |
14 | Famer D & Crisby M (2007). Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-l- mice exposed to a high cholesterol diet. Neurosci Lett. 419:68-73 DOI ScienceOn |
15 | Akiba T, Shibuta T, Amano Y, Koga T & Takimoto M (1999). 28-day repeated oral toxicity study of a hypolipidemic agent, NK-104 in rats. J Toxicol Sci 5:701-711 |
16 | Lamperti C, Naini AB, Lucchini V, Moggio M, Sciacco M, Kaufmann P & DiMauro S (2005). Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol 62:1709-1712 DOI ScienceOn |
17 | Susic D, Varagic J, Ahn J, slama M & Frohlich ED (2003). Beneficial pleitropic vascular effects of rosuvastatin in two hypertensive models. J Am Coll Cardiol 42:1091-1097 DOI ScienceOn |
18 | Mabuchi H, Nohara A, Katsuda S, Inatsuda S & Koizumi J (2007). Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized doubleblind study. Lipid Research 195:e182-189 |
19 | Kaneta S, Satoh K, Kanda M & Ichihara K (2003). All hydrophobic HMG coA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cell. Athrosclerosis 170:237-243 DOI ScienceOn |
20 | Lankas GR, Cukierski MA & Wise LD (2004). The role of maternal toxicity in lovastatin-induced developmental toxicity. Birth Defects Res B Dev Reprod Toxicol 71:111-123 DOI ScienceOn |
21 | Dajani EZ, Shahwan TG & Dajani NE (2002). Statins, platelet aggregation and coronary heart disease. J Assoc Acad Minor Phys 13:27-31 |
22 | Liu CH, Huang MT & Huang PC (1995). Source of triglyceride accumulation in livers of rats fed a cholesterol supplemented diet. Lipids 30:527-531 DOI |
23 | Terao J, Piskula M & Yao Q. (1994) Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers.. Arch Biochem Biophys 308:278-284 DOI ScienceOn |
24 | Dhanasekaran M & Ren J (2005). The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2:447-459 DOI ScienceOn |
25 | Galus R, Włodarski P & Włodarski K (2006) Influence of fluvastatin on bone formation induced by demineralized bone matrix in mice. Pharmacol Rep 58:443-447 |
26 | Broncel M, Koter-Michalak M & Chojnowska-Jezierska J (2006). The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek 63:738-742 |
27 | Mabuchi H, Higashikata T, Kawashiri M, Inazu A, Koizumi J & Kobayashi J (2005). Reduction of serum ubiquinol-10 and ubiquinone- 10 levels by atorvastatin in hypercholesterolemic patients. J Atheroscler Thromb 12:111-119 DOI ScienceOn |
28 | Staal A, Frith JC, Fewnch MH, Stuwartz J, Rogers MJ & Feyen JH (2003) The ability of statins to inhibit bone reabsorption is directly related to their inhibitory effect on HMG coA reductase activity. J Bone Mineral Res 18:88-96 DOI ScienceOn |
29 | Bandoh T, Mitani H, Niihashi M, Totsuka T, Sakurai I & Hayashi S (2000). Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition. J Cardiovasc Pharmacol 35:136-144 DOI ScienceOn |
30 | Osada K, Takahashi M, Hoshina S, Nakamura S & Sugano M (2001) Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol C Toxicol Pharmacol 128:153-164 DOI ScienceOn |
31 | Mason RP, Walter MF, Day CA & Jacob RF (2006). Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism. J Biol Chem 281:9337-9345 DOI ScienceOn |
32 | Sayama K, Lin SX, Zheng GD & Oguni I (2003). Antiobee effects of green tea powder and its components. International Symposium on Green tea. KFN Conference, 7:55-62 |
33 | West KL & Fernandez ML (2004). Guinea pigs as models to study the hypocholesterolemic effects of drugs. Cardiovasc Drug Rev. 22:55-70 DOI ScienceOn |
34 | Maridonneau I, Braquet P &, Garay RP (1983). Na+ and K+ transport damage induced by oxygen free radicals in human red blood cell membranes. Biol Chem 285:3107-3113 |
35 | Matsuno H, Takei M, Hayashi H, Nakajima K & Kozawa O (2004). Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J Cardiovasc Pharmacol 43:333-340 DOI ScienceOn |
36 | Tziakas DN, Kaski JC, Chalikias GK, Bomero C, Hatseras DI & Holt DW (2007). Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability. J Am Coll Cardiol 49:2081-2089 DOI ScienceOn |
37 | Folch J, Lee M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509 |
38 | Mitane Y, Miwa Sagesaka M & Okada S (1990). Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull 38:790-793 DOI ScienceOn |
39 | Uyuklu M, Meiselman HJ & Baskurt OK (2007). Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. Clin Hemorheol Microcirc 36:25-33 |
40 | Draper HH & Callant AS (1969). A simplified hemolysis test for vitamin E deficiency. J Nutr 98:390-394 DOI |
41 | Ryszawa N, Kawczyńska-Drózdz A, Adamek-Guzik T, Korbut R & Guzik TJ (2006). Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis. J Physiol Pharmacol 57:611-626 |
42 | Broncel M, Balcerak M, Sikora J & Chojnowska-Jezierska J (2007). Effect of fluvastatin extended release on the protein-lipid structure of erythrocyte membrane and C-reactive protein in patients with hyperlipidemia. Polski merkuriusz lekarski 22:107-111 |
43 | Haramaki N, Ikeda H, Takenaka K, Matsuoka H & Imaizumi T (2007) Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arteriosclerm Thromb Vascular Biol. 27:1471-1477 DOI ScienceOn |
44 | Villa E, Rábano A, Albarrán OG, Ruilope LM & García-Robles R (1998). Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs. Am J Hypertens 11:844-851 DOI ScienceOn |
45 | Saffari Y & Sadrzadeh SM (2004). Green tea metabolite EGCG protects membranes against oxidative damage in vitro. Life Sci 6; 74:1513-1518 DOI |
46 | Littarru GP & Langsjoen P (2007). Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 7:168-174 DOI ScienceOn |